CD24 and ovarian carcinoma: The fold changein CD24 was remarkable with ∼50-fold up-regulation observed inthree of the five chosen array studies which reported fold change values.Cytoplasmic localisation of CD24 has been shown to be associated with poor survivaland CD24 has been investigated as a therapeutic target in ovarian cancer [37],[38].